SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Avaxia Biologics, Inc. Receives IND Clearance From FDA to Initiate Clinical Program to Evaluate AVX-470 as Therapy for Ulcerative Colitis